Carmen Berasain

Instituto de Salud Carlos III — Spain

Medicine · Health Sciences

51h-index8.4kcitations221works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(42), Liver physiology and pathology(35), RNA modifications and cancer(33), Epigenetics and DNA Methylation(28), RNA Research and Splicing(15)

Publications221 total

Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma
2025
Demonstration of SLU7 as a new cancer target
Biomedicine & Pharmacotherapy·2025Open Access
Demonstration of SLU7 as a new pan-cancer target
2025Open Access
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma
2025Open Access
Gut-to-bile transfer of microbially amidated minor bile acids in patients with hepatopancreatobiliary disorders
Hepatology·2025· 3 citedOpen Access
Expression landscape of epigenetic genes in human hepatocellular carcinoma
Journal of Physiology and Biochemistry·2025· 4 citedOpen Access
SAT-064 Expression and role of trefoil factor 3 (TFF3) in hepatoblastoma
Journal of Hepatology·2025
THU-487 Liver-targeted mRNA therapeutics through fibroblast growth factor 21 and apolipoprotein A1 delivery in experimental acute pancreatitis
Journal of Hepatology·2025
WED-057 Microbially conjugated bile salts undergo hepatobiliary secretion in humans and mice
Journal of Hepatology·2025
WED-068 Enterohepatic circulation of microbial bile acid conjugates
Journal of Hepatology·2025
Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
UNC Libraries·2025Open Access
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
UNC Libraries·2025Open Access
Mutational Analysis of Bile Cell‐Free DNA in Primary Sclerosing Cholangitis: A Pilot Study
Liver International·2025· 3 citedOpen Access
FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis
Journal of Translational Medicine·2025· 4 citedOpen Access
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
Journal of Experimental & Clinical Cancer Research·2025· 13 citedOpen Access
New Insights and Open Questions on the Molecular and Cellular Crosstalk Governing Hepatocyte Proliferation
Cellular and Molecular Gastroenterology and Hepatology·2025Open Access
Mouse models of primary sclerosing cholangitis: we just can’t get enough
Metabolism and Target Organ Damage·2024· 2 citedOpen Access
Bile liquid biopsy improves the diagnostic accuracy of biliary stenosis secondary to pancreatic ductal adenocarcinoma
Pancreatology·2024
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression
Journal of Physiology and Biochemistry·2024Open Access
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
Clinical Science·2024· 7 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Matías A. Ávila(44), Jesús Prìeto(24), María U. Latasa(23), Maite G. Fernández‐Barrena(15), Iker Uriarte(12), Josefa Castillo(10), Raquel Urtasun(10), Bruno Sangro(9), María Elizalde(9), María Arechederra(9), María J. Perugorria(7), Fernando J. Corrales(7), Elena R. García–Trevijano(7), Saioa Goñi(7), Gloria Álvarez‐Sola(6), Marina Bárcena‐Varela(6), Leticia Colyn(6), Oihane García‐Irigoyen(6), José M. Mato(5), Simone Carotti(5)